시장보고서
상품코드
1274671

세계의 강경증 치료 시장 보고서(-2023년)

Catalepsy Treatment Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

강경증 치료 세계 시장은 2022년 760억 3,000만 달러에서 2023년 811억 5,000만 달러에 달하고, CAGR 6.7%로 성장할 것으로 예상됩니다. 러시아-우크라이나 전쟁은 적어도 단기적으로는 코로나19 팬데믹으로 인한 세계 경제 회복 가능성을 혼란스럽게 만들었습니다. 양국 간의 전쟁은 여러 국가에 대한 경제 제재, 상품 가격 상승, 공급망 혼란으로 이어져 상품과 서비스 전반에 걸쳐 인플레이션을 유발하고 세계 많은 시장에 영향을 미치고 있습니다. 강경증 치료 시장은 2027년까지 연평균 6.2%의 CAGR로 1,033억 2,000만 달러 규모로 성장할 것으로 예상됩니다.

북미는 2022년 강경증 치료 시장에서 가장 규모가 큰 지역이 될 것입니다. 강경증 치료 시장 보고서의 대상 지역은 아시아태평양, 서유럽, 중동 및 북유럽, 북미, 남미, 중동 및 아프리카입니다.

만성 질환의 유병률 증가는 향후 강경증 치료 시장을 촉진할 것으로 예상됩니다. 만성질환은 보통 3개월 이상 지속되고 시간이 지남에 따라 악화될 수 있는 질병이나 상태를 말합니다. 대부분의 만성질환은 관리할 수 있지만 치료할 수 없는 질환으로, 일반적으로 노년층이 많이 앓고 있습니다. 만성 질환과 관련된 다른 독성 질환 및 감염과 함께 강경증 유병률이 증가하고 있어 강경증 치료가 필요한 상황입니다. 예를 들어, 미국에 본부를 둔 국제 공중보건 전문기관인 세계보건기구(WHO)에 따르면, 2022년 9월에는 세계 전체 사망자의 74%에 해당하는 약 4,100만 명이 만성 비감염성 질환(NCD)으로 인해 매년 사망할 것으로 예상하고 있습니다. 또한, NCD로 인한 사망자의 약 77%는 중저소득 국가에서 발생하는 것으로 알려져 있습니다. 따라서 만성질환의 확산이 강경증 치료 시장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 강경증 치료 시장 특징

제3장 강경증 치료 시장 동향과 전략

제4장 강경증 치료 시장 - 거시경제 시나리오

  • COVID-19에 의한 강경증 치료 시장에 대한 영향
  • 우크라이나·러시아 전쟁이 강경증 치료 시장에 미치는 영향
  • 고인플레이션이 강경증 치료 시장에 미치는 영향

제5장 강경증 치료 시장 규모와 성장

  • 세계의 강경증 치료 시장 실적, 2017-2022년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 강경증 치료 시장 예측, 2017-2022, 2022-2027F, 2032F
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 강경증 치료 시장 세분화

  • 세계의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 약물
  • 심리치료
  • 기타 유형
  • 세계의 강경증 치료 시장, 투여 경로별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 경구
  • 비경구
  • 기타 경로
  • 세계의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 전문 클리닉
  • 기타 사용자

제7장 강경증 치료 시장 : 지역 및 국가별 분석

  • 세계의 강경증 치료 시장, 지역별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 강경증 치료 시장, 국가별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양의 강경증 치료 시장

  • 아시아태평양의 강경증 치료 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 규제, 규제기관, 주요 단체, 과세액, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 강경증 치료 시장

  • 중국의 강경증 치료 시장 개요
  • 중국의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중국의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 강경증 치료 시장

  • 인도의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 강경증 치료 시장

  • 일본의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 강경증 치료 시장

  • 호주의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 호주의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 강경증 치료 시장

  • 인도네시아의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 강경증 치료 시장

  • 한국의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 강경증 치료 시장

  • 서유럽의 강경증 치료 시장 개요
  • 서유럽의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 강경증 치료 시장

  • 영국의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 영국의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 강경증 치료 시장

  • 독일의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 독일의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 강경증 치료 시장

  • 프랑스의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 강경증 치료 시장

  • 동유럽의 강경증 치료 시장 개요
  • 동유럽의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 강경증 치료 시장

  • 러시아의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 강경증 치료 시장

  • 북미의 강경증 치료 시장 개요
  • 북미의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 북미의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 강경증 치료 시장

  • 미국의 강경증 치료 시장 개요
  • 미국의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 미국의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 강경증 치료 시장

  • 남미의 강경증 치료 시장 개요
  • 남미의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 남미의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 강경증 치료 시장

  • 브라질의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 강경증 치료 시장

  • 중동의 강경증 치료 시장 개요
  • 중동의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중동의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 강경증 치료 시장

  • 아프리카의 강경증 치료 시장 개요
  • 아프리카의 강경증 치료 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카의 강경증 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제27장 강경증 치료 시장 경쟁 구도와 기업 개요

  • 강경증 치료 시장 경쟁 구도
  • 강경증 치료 시장 기업 개요
    • Upsher-Smith Laboratories LLC
    • Piramal Enterprises Ltd.
    • Vintage Labs Private Limited
    • Hikma Pharmaceuticals Plc.
    • CASI Pharmaceuticals Inc.

제28장 강경증 치료 시장의 주요 인수합병(M&A)

제29장 강경증 치료 시장 전망과 가능성 분석

제30장 부록

LSH 23.05.25

“Catalepsy Treatment Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on catalepsy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for catalepsy treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The catalepsy treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Drugs; Psychotherapy; Other Types
  • 2) By Route of Administration: Oral; Parenteral; Other Routes
  • 3) By End User: Hospitals; Specialty Clinics; Other Users
  • Companies Mentioned: Upsher-Smith Laboratories LLC; Piramal Enterprises Ltd.; Vintage Labs Private Limited; Hikma Pharmaceuticals Plc.; CASI Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the catalepsy treatment market are Upsher-Smith Laboratories LLC, Piramal Enterprises Ltd., Vintage Labs Private Limited, Hikma Pharmaceuticals Plc., CASI Pharmaceuticals Inc., Covis Pharma GmbH, GSK Plc., Bayer AG, Novartis AG, Aleva Neurotherapeutics SA, Sanofi S.A., Takeda Pharmaceutical Company Limited, Roche Holding AG, Abbott Laboratories, Pfizer Inc., Johnson & Johnson Services Inc., Dr Reddy's Laboratories Ltd., Mylan N.V., Eisai Co. Ltd., and Glenmark Pharmaceuticals Limited.

The global catalepsy treatment market is expected to grow from $76.03 billion in 2022 to $81.15 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The catalepsy treatment market is expected to grow to $103.32 billion in 2027 at a CAGR of 6.2%.

The catalepsy treatment market consists of sales of benzodiazepines and zolpidem. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Catalepsy treatment refers to a procedure that focuses on reducing the symptoms of catalepsy like loss of voluntary motion, fixed posture, and decreased sensitivity to pain by using medication and muscle relaxants. They are used for reducing muscle rigidity.

North America was the largest region in the catalepsy treatment market in 2022. The regions covered in the catalepsy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of catalepsy treatment are drugs, psychotherapy, and others. Drugs are any substances used to treat, diagnose, or relieve the symptoms of a disease or other abnormal state. These are administered through oral, parenteral, and other routes, used by hospitals, specialty clinics, and other end-users.

The growing prevalence of chronic diseases is expected to propel the catalepsy treatment market going forward. Chronic conditions are illnesses or conditions that typically endure for three months or longer and may deteriorate over time. The majority of chronic diseases can be managed but not cured, and they typically affect older persons. The prevalence of catalepsy is rising along with other toxic or infectious diseases linked to chronic illnesses, requiring catalepsy treatment. For instance, in September 2022, according to the World Health Organization, a US-based specialized agency responsible for international public health, about 41 million people will die each year, which is equivalent to 74% of all deaths globally, because of chronic noncommunicable diseases (NCD). Further, all the NCD deaths will be around 77% in low- and middle-income countries. Therefore, the growing prevalence of chronic diseases is driving the catalepsy treatment market.

Product innovation is a key trend gaining popularity in the catalepsy treatment market. Major companies operating in the catalepsy treatment market are focused on developing innovative solutions to strengthen their market position. For instance, in July 2021, Hikma Pharmaceuticals PLC, a UK-based manufacturer of non-branded generic and in-licensed pharmaceutical products, launched Succinylcholine Chloride Injection, a muscle relaxant that provides skeletal muscle relaxation or mechanical ventilation. It is uniquely designed with a neuromuscular blocking agent that facilitates tracheal intubation and general anesthesia, which can help treat patients faster and more easily.

In November 2021, Sanofi S.A., a France-based biopharmaceutical company focused on rare diseases and long-term chronic conditions, acquired Kadmon Holdings, Inc. for an undisclosed amount. Through this acquisition, combined resources with Kadmon's are expected to enable Sanofi to strengthen and expand the general medicine portfolio. Kadmon Holdings, Inc. is a US-based biopharmaceutical company that discovers and develops transformative therapies for unmet medical needs.

The countries covered in the catalepsy treatment market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The catalepsy treatment market research report is one of a series of new reports from The Business Research Company that provides catalepsy treatment market statistics, including catalepsy treatment industry global market size, regional shares, competitors with a catalepsy treatment market share, detailed catalepsy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the catalepsy treatment industry. This catalepsy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Catalepsy Treatment Market Characteristics

3. Catalepsy Treatment Market Trends And Strategies

4. Catalepsy Treatment Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Catalepsy Treatment Market
  • 4.2. Ukraine-Russia War Impact On Catalepsy Treatment Market
  • 4.3. Impact Of High Inflation On Catalepsy Treatment Market

5. Catalepsy Treatment Market Size And Growth

  • 5.1. Global Catalepsy Treatment Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Catalepsy Treatment Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Catalepsy Treatment Market Segmentation

  • 6.1. Global Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Drugs
  • Psychotherapy
  • Other Types
  • 6.2. Global Catalepsy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral
  • Parenteral
  • Other Routes
  • 6.3. Global Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other Users

7. Catalepsy Treatment Market Regional And Country Analysis

  • 7.1. Global Catalepsy Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Catalepsy Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Catalepsy Treatment Market

  • 8.1. Asia-Pacific Catalepsy Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Catalepsy Treatment Market

  • 9.1. China Catalepsy Treatment Market Overview
  • 9.2. China Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Catalepsy Treatment Market

  • 10.1. India Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Catalepsy Treatment Market

  • 11.1. Japan Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Catalepsy Treatment Market

  • 12.1. Australia Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Catalepsy Treatment Market

  • 13.1. Indonesia Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Catalepsy Treatment Market

  • 14.1. South Korea Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Catalepsy Treatment Market

  • 15.1. Western Europe Catalepsy Treatment Market Overview
  • 15.2. Western Europe Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Catalepsy Treatment Market

  • 16.1. UK Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Catalepsy Treatment Market

  • 17.1. Germany Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Catalepsy Treatment Market

  • 18.1. France Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Catalepsy Treatment Market

  • 19.1. Eastern Europe Catalepsy Treatment Market Overview
  • 19.2. Eastern Europe Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Catalepsy Treatment Market

  • 20.1. Russia Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Catalepsy Treatment Market

  • 21.1. North America Catalepsy Treatment Market Overview
  • 21.2. North America Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Catalepsy Treatment Market

  • 22.1. USA Catalepsy Treatment Market Overview
  • 22.2. USA Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Catalepsy Treatment Market

  • 23.1. South America Catalepsy Treatment Market Overview
  • 23.2. South America Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Catalepsy Treatment Market

  • 24.1. Brazil Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Catalepsy Treatment Market

  • 25.1. Middle East Catalepsy Treatment Market Overview
  • 25.2. Middle East Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Catalepsy Treatment Market

  • 26.1. Africa Catalepsy Treatment Market Overview
  • 26.2. Africa Catalepsy Treatment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Catalepsy Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Catalepsy Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Catalepsy Treatment Market Competitive Landscape
  • 27.2. Catalepsy Treatment Market Company Profiles
    • 27.2.1. Upsher-Smith Laboratories LLC
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Piramal Enterprises Ltd.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Vintage Labs Private Limited
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Hikma Pharmaceuticals Plc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. CASI Pharmaceuticals Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Catalepsy Treatment Market

29. Catalepsy Treatment Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제